Lyell Immunopharma Inc (LYEL) is around the top of the Biotechnology industry according to InvestorsObserver. LYEL received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Lyell Immunopharma Inc also achieved a score of 74 in the Biotechnology industry, putting it above 74 percent of Biotechnology stocks. Biotechnology is ranked 16 out of the 148 industries.
LYEL has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on LYEL!